Pituitary carcinoma: a review of the literature
- PMID: 15191336
- DOI: 10.3171/foc.2004.16.4.8
Pituitary carcinoma: a review of the literature
Abstract
Pituitary carcinomas, defined as distant metastases of a pituitary neoplasm, are rare; fewer than 140 reports exist in the English literature. The initial presenting pituitary tumor is usually a secreting, invasive macroadenoma, with adrenocorticotropic hormone (ACTH)--and prolactin (PRL)--secreting tumors being the most common. The latency period between the diagnosis of a pituitary tumor and the diagnosis of a pituitary carcinoma is 9.5 years for ACTH-producing lesions and 4.7 years for PRL-secreting tumors. Survival after documentation of metastatic disease is poor; 66% of patients die within 1 year. Treatment options include additional surgery, radiotherapy, and chemotherapy, all of which are associated with poor results. Future studies will focus on identifying those invasive pituitary tumors most likely to metastasize and treating them aggressively before they progress to pituitary carcinomas.
Comment in
-
Metastases from nonfunctioning pituitary carcinomas.Neurosurg Focus. 2005 Sep 15;19(3):E11; author reply E11. doi: 10.3171/foc.2005.19.3.12. Neurosurg Focus. 2005. PMID: 16196164 No abstract available.
Similar articles
-
Evolution of a refractory prolactin-secreting pituitary adenoma into a pituitary carcinoma: report of a challenging case and literature review.BMC Endocr Disord. 2021 Oct 29;21(1):217. doi: 10.1186/s12902-021-00874-8. BMC Endocr Disord. 2021. PMID: 34715828 Free PMC article. Review.
-
Adrenocorticotropic hormone-producing pituitary carcinoma with intracranial metastases.World Neurosurg. 2013 Feb;79(2):404.e11-6. doi: 10.1016/j.wneu.2011.04.018. Epub 2011 Nov 10. World Neurosurg. 2013. PMID: 22079280
-
Pituitary carcinomas.Front Horm Res. 2010;38:94-108. doi: 10.1159/000318499. Epub 2010 Jul 5. Front Horm Res. 2010. PMID: 20616500 Review.
-
Diagnosis and treatment of pituitary adenomas.Minerva Endocrinol. 2004 Dec;29(4):241-75. Minerva Endocrinol. 2004. PMID: 15765032 Review.
-
Pituitary carcinoma: a clinicopathologic study of 15 cases.Cancer. 1997 Feb 15;79(4):804-12. doi: 10.1002/(sici)1097-0142(19970215)79:4<804::aid-cncr18>3.0.co;2-3. Cancer. 1997. PMID: 9024719
Cited by
-
The regulatory role and clinical application prospects of circRNA in the occurrence and development of CNS tumors.CNS Neurosci Ther. 2024 Apr;30(4):e14500. doi: 10.1111/cns.14500. Epub 2023 Nov 12. CNS Neurosci Ther. 2024. PMID: 37953502 Free PMC article. Review.
-
Case report: Identification of potential prognosis-related LAG3 overexpression and DICER1 mutation in pituitary carcinoma: two cases.Front Neurosci. 2023 Oct 12;17:1191596. doi: 10.3389/fnins.2023.1191596. eCollection 2023. Front Neurosci. 2023. PMID: 37901430 Free PMC article.
-
Recent Therapeutic Advances in Pituitary Carcinoma.J Immunother Precis Oncol. 2022 Dec 13;6(2):74-83. doi: 10.36401/JIPO-22-25. eCollection 2023 May. J Immunother Precis Oncol. 2022. PMID: 37214211 Free PMC article. Review.
-
The Party Wall: Redefining the Indications of Transcranial Approaches for Giant Pituitary Adenomas in Endoscopic Era.Cancers (Basel). 2023 Apr 10;15(8):2235. doi: 10.3390/cancers15082235. Cancers (Basel). 2023. PMID: 37190164 Free PMC article. Review.
-
Natural history of pituitary carcinoma with metastasis to the cervical spine: illustrative case.J Neurosurg Case Lessons. 2023 Jan 16;5(3):CASE22363. doi: 10.3171/CASE22363. Print 2023 Jan 16. J Neurosurg Case Lessons. 2023. PMID: 36647250 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
